NanoDx ™Announces Licensing Collaboration with IBM Research for the Design and Manufacturing of Nanoscale Sensors for Rapid Diagnostic Testing
NanoDx™ System pursuing FDA Emergency Use Authorization to expand rapid COVID-19 testing
Focused on identification and management of the long-term issues associated with Traumatic Brain Injury in both active and retired military personnel.
Widespread point-of-care (POC) and at-home diagnostics have long been widely held goals. However, that hasn’t been widely translated into reality. Startup Nanodiagnostics Inc. has been working for years toward a panel of POC tests, helmed by one for traumatic brain...
Boston, MA – BioDirection®, Inc. d/b/a NanoDiagnosticsTM, Inc. (NanoDxTM), a privately held medical device company developing cutting-edge and rapid point-of-care in-vitro diagnostic products for the objective detection, diagnosis and management of Traumatic Brain...
Traumatic brain injury is a signature wound of the wars in Iraq and Afghanistan. But the military still has no objective way of diagnosing it in the field.
DoD guidance and the latest traumatic brain injury research, led to an overhauling of how TBIs are assessed and managed in the military.